Detalhe da pesquisa
1.
CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathology.
Eur J Nucl Med Mol Imaging
; 51(5): 1383-1394, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38082196
2.
Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [18F]FDG.
Eur J Nucl Med Mol Imaging
; 51(3): 749-755, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37943339
3.
Modelling the In Vivo and Ex Vivo DNA Damage Response after Internal Irradiation of Blood from Patients with Thyroid Cancer.
Int J Mol Sci
; 25(10)2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791531
4.
Lack of repeatability of radiomic features derived from PET scans: Results from a 18 F-DCFPyL test-retest cohort.
Prostate
; 83(6): 547-554, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632656
5.
Test-retest repeatability of organ uptake on PSMA-targeted 18 F-DCFPyL PET/CT in patients with prostate cancer.
Prostate
; 83(12): 1186-1192, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37211963
6.
[18F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
Eur J Nucl Med Mol Imaging
; 50(6): 1699-1708, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670283
7.
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors.
Eur J Nucl Med Mol Imaging
; 50(10): 3011-3021, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37147478
8.
SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T.
Eur J Nucl Med Mol Imaging
; 50(11): 3465-3474, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272956
9.
Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 50(12): 3765-3776, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474735
10.
Deep phenotyping as a contribution to personalized depression therapy: the GEParD and DaCFail protocols.
J Neural Transm (Vienna)
; 130(5): 707-722, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36959471
11.
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL.
Mol Imaging
; 2022: 7056983, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35283693
12.
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy.
Prostate
; 82(14): 1406-1412, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35860909
13.
Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myeloma.
Br J Haematol
; 198(3): 515-522, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582835
14.
Repair of α-particle-induced DNA damage in peripheral blood mononuclear cells after internal ex vivo irradiation with 223Ra.
Eur J Nucl Med Mol Imaging
; 49(12): 3981-3988, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35759008
15.
CXCR4-targeted theranostics in oncology.
Eur J Nucl Med Mol Imaging
; 49(12): 4133-4144, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674738
16.
Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging
; 49(9): 3269-3276, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243517
17.
Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens.
Eur J Nucl Med Mol Imaging
; 49(11): 3938-3949, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35556160
18.
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up.
Eur J Nucl Med Mol Imaging
; 49(12): 4262-4270, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35650263
19.
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease.
Eur J Nucl Med Mol Imaging
; 49(13): 4727-4735, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852555
20.
Questionable value of [99mTc]-sestamibi scintigraphy in patients with pHPT and negative ultrasound.
Langenbecks Arch Surg
; 407(8): 3661-3669, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35945299